Search Results 581-590 of 17518 for treatment resistant depression
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison Satake. April 7, 2025.
Clinical Trials · Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · More about research at Mayo Clinic · Mayo ...
... drug-resistant. Featured News. New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison ...
... drug regimen) TB infection. If the current incidence rates of multi-drug resistant TB infection in the locale are unavailable, an adequate treatment regimen ...
New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant ... treatment strategies for most severe forms of ...
— A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an ...
Age ≥ 18 years. · Must have RRMM after having received prior exposure to at least 3 prior lines of therapies in addition to being refractory to a Proteasome ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!